Delivery Order SPE2DE24DA010-SPE2D626F514E
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 17, 2025. The contract utilizes fixed-price pricing with economic price adjustment and represents a child delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation, reflecting...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $11,750.00 from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025, with performance extending through December 4, 2025. The contract employs a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. This delivery order represents a discrete task order issued under Abbott's broader...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695 by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with an ultimate completion date of January 6, 2026. This fixed-price delivery order with economic price adjustment carries no set-aside designation and represents a task order executed under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc. through its Abbott Vascular Inc. division received a $11,750 fixed-price delivery order (4570134220) from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025, with completion targeted for December 1, 2025. The award carries no set-aside designation and represents work to be performed in Santa Clara, California. This delivery order falls under Abbott Vascular's established cardiovascular medical technology portfolio, which includes specialized...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $41,268 under the Defense Logistics Agency's Medical Supply Chain program, awarded on December 5, 2025, with performance completion targeted for December 10, 2025. This fixed-price contract with economic price adjustment mechanism was awarded through full and open competition with no set-aside designation to Abbott Vascular at its Santa Clara, California location. The Defense Logistics Agency...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F514EDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570109351) valued at $6,874.00 from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by December 1, 2025. The award carries no set-aside designation and represents a discrete delivery order issued under Abbott's established indefinite delivery contract vehicle with the Defense Logistics Agency, which provides comprehensive cardiovascular procedural packages including devices, instrumentation, accessories, and related medical technologies. Performance will take place at Abbott's facility in Santa Clara, California. This delivery order supports the federal government's ongoing procurement of cardiovascular medical supplies and equipment for military and defense healthcare operations. Abbott Vascular has established itself as a critical supplier to the Department of Defense and Defense Logistics Agency through its extensive portfolio of advanced cardiovascular technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, and transcatheter valve repair systems such as MitraClip. The company's strategic importance to federal healthcare procurement is underscored by its $117.1 million indefinite delivery contract with the Defense Logistics Agency, which has generated numerous task orders throughout 2024 and 2025, demonstrating Abbott's competitive positioning and sustained capability to support complex medical procedures and enhance patient outcomes across military healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/24/25 |